Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment
Authors:
- Xiaopeng BaiXBXiaopeng Bai
- Stephen M. CollinsSCStephen M. Collins
- 22 April 2024
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 56 (11) , 1805-1809
Abstract
No abstract availableKeywords
Funding Information
- W. Garfield Weston Foundation
- Canadian Institutes of Health Research
- W Garfield Weston Foundation
This publication has 60 references indexed in Scilit:
- Fecal microbiota-based treatment for recurrent Clostridioides difficile infectionCell, 2023
- The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapsesMicrobiologyopen, 2020
- The effect of antibiotics on the composition of the intestinal microbiota - a systematic reviewJournal of Infection, 2019
- Clostridium difficile toxin B induces senescence in enteric glial cells: A potential new mechanism of Clostridium difficile pathogenesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2018
- Probiotics to Prevent Clostridium difficile Infection in Patients Receiving AntibioticsJAMA, 2018
- Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?Cellular and Molecular Life Sciences, 2017
- Experience and Outcomes at a Specialized Clostridium difficile Clinical PracticeMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2017
- Enteric glial cells are susceptible to Clostridium difficile toxin BCellular and Molecular Life Sciences, 2016
- Clostridium difficile: A European perspectiveJournal of Infection, 2013
- Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infectionJournal of Hospital Infection, 2011